Saturday, March 4

7:30 am – 5:30 pm

Registration Open

8:00 am – 9:00 am

General Session


Imaging for Urologic Issues: Which Test and When?

1.0 CH

Parvati Ramchandani, MD

A plethora of imaging techniques and modalities are available to evaluate patients with urologic issues. This talk will address the appropriate imaging for clinical problems commonly encountered in patients presenting to a urology clinic, using a case-based scenario. Imaging issues in challenging patients also will be discussed.

9:00 am – 10:45 am

Exhibits Open / Continental Breakfast

10:50 am – 11:50 am

General Session


Managing GI/GU Ostomies

1.0 CH

William Falone, MSN, RN, CWON
Liza Thomas, DNP, CRNP

Managing and understanding a urostomy requires a bit more awareness of the details compared to a fecal ostomy. Understanding these details will help clinicians better serve the needs of the ostomate. This session also will include common types of urinary diversions seen in an acute care setting and tidbits on how they are managed in the immediate postoperative period.

11:50 am – 1:05 pm

Lunch / Product Theater (Non-CE)


Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment

Diane K. Newman, DNP, CRNP, FAAN, BCB-PMD

Sponsored by Urovant Sciences

1:10 pm – 2:10 pm

General Session


Update on Immunotherapy for Renal Cell Carcinoma

1.0 CH

Naomi Haas, MD

Several types of immunotherapies can be used to treat kidney cancer. This session will discuss the best information available about the various types of immunotherapy treatments.

2:20 pm – 3:20 pm

Concurrent Sessions


Prostate Cancer Biomarkers: What to Choose and When to Use

1.0 CH

Rachel Hastings, MS, PA-C

This session will review prostate cancer biomarkers available throughout each disease state from early detection to advanced disease.


Overview of Vaginitis and Vulvodynia

1.0 CH

Rebecca Stephens, MSN, CRNP

What is new in terms of evaluation and management of vaginitis and vulvodynia.

3:30 pm – 4:30 pm

Concurrent Sessions


Benign Prostatic Hypertrophy: Medical and Surgical Management in 2023

1.0 CH

Steven Sterious, MD

How do you assess and treat benign prostatic hyperplasia (BPH)? Learn about the current non-surgical and traditional and less invasive surgical approaches to managing patients with BPH.


Compounded Medications for Urologic Conditions

1.0 CH

Tara Thompson, PharmD

Compounded medications can fill the gap and increase patient access to the medications they need for conditions such as erectile dysfunction, Peyronie’s disease, premature ejaculation, or disorders such as vulva/vestibulodynia, vaginal atrophy, and hypertonic pelvic floor.

4:40 pm – 5:40 pm

General Session


Complementary Therapies for Common Bladder Symptoms and Conditions

1.0 CH

Catherine McGinty, FNP-BC

A comprehensive look at complementary therapies for common bladder symptoms and conditions, with a special emphasis on treatments that target the neuromuscular process of bladder health, including myofascial trigger point injections, suppositories, and temperature-related therapies.

< View the schedule for Friday

View the schedule for Sunday <